Angelos Stergiou
Founder at SELLAS LIFE SCIENCES GROUP, INC.
Net worth: 177 301 $ as of 2024-03-30
Profile
Angelos M.
Stergiou founded Sellas Life Sciences Group Ltd.
in 2012, where he is working as Vice Chairman & Chief Executive Officer from 2012, SELLAS Life Sciences Group, Inc. in 2006, where he is working as President, Chief Executive Officer & Director from 2017, and Genesis Research LLC in 2009, where he worked as President, Chief Executive & Operating Officer from 2009 to 2011.
Dr. Stergiou also currently works at Cleara Biotech BV, as Chairman from 2022, New York Academy of Sciences, as Member, Academy of Physicians In Clinical Research, as Member, Association of Clinical Research Professionals, as Member, and The World Medical Association, as Member.
Dr. Stergiou also formerly worked at SELLAS Life Sciences Group, Inc., as Chief Executive Officer & Director, Cleara Biotech BV, as Director, BioVest International, Inc., as Chief Medical Officer & Vice President from 2004 to 2008, Accentia Biopharmaceuticals, Inc., as Vice President & Head-Drug Development from 2004 to 2008, Kentucky Wesleyan College, as Trustee from 2017 to 2021, and Anavex Life Sciences Corp., as VP-Clinical Development & Medical Affairs.
Dr. Stergiou received his doctorate degree from Kentucky Wesleyan College and undergraduate degree in 1997 from Kentucky Wesleyan College.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-01-21 | 175,546 ( 0.31% ) | 177 301 $ | 2024-03-30 |
Angelos Stergiou active positions
| Companies | Position | Start |
|---|---|---|
| SELLAS LIFE SCIENCES GROUP, INC. | Founder | 2006-04-02 |
Sellas Life Sciences Group Ltd.
 Sellas Life Sciences Group Ltd. Pharmaceuticals: MajorHealth Technology Sellas Life Sciences Group Ltd. manufactures pharmaceutical products. It focuses on innovative products to treat cancer and central nervous system diseases. The firm’s product candidate, licensed from Memorial Sloan-Kettering Cancer Center is a late-stage innovative WT1-targeting synthetic heteroclitic epitope immunotherapeutic in development for hematological malignancies and solid tumors characterized by an overexpression of the WT1 (Wilms Tumor Protein) antigen. The company was founded by Angelos M. Stergiou in 2012 and is headquartered in Zug, Switzerland. | Founder | 2011-12-31 |
| The World Medical Association | Corporate Officer/Principal | - |
| Academy of Physicians In Clinical Research | Corporate Officer/Principal | - |
Association of Clinical Research Professionals
 Association of Clinical Research Professionals Miscellaneous Commercial ServicesCommercial Services The Association of Clinical Research Professionals is a non-profit organization that provides over 50 online and in-person training programs for individual sale and institutional licensing. The non-profit company is based in Alexandria, VA and was founded by Lynn E. Regina. The company's courses cover good clinical practice (GCP) and specialized topics, including the anatomy of a protocol, hypothesis development, study design, subject safety, and data integrity risk considerations. The company also offers clinical trial insights research, a solution that combines market research capabilities with unprecedented access. With over 13,000 members, the organization represents, supports, and advocates for clinical research professionals. | Corporate Officer/Principal | - |
New York Academy of Sciences
 New York Academy of Sciences Miscellaneous Commercial ServicesCommercial Services New York Academy of Sciences is an independent, not-for-profit organization, which engages in the advancement of scientific research, education, and policy. The company was founded in 1817 and is headquartered in New York, NY. | Corporate Officer/Principal | - |
Cleara Biotech BV
 Cleara Biotech BV Pharmaceuticals: MajorHealth Technology Cleara Biotech BV operates as a biopharmaceutical company. It specializes in identification and specific elimination of subtypes of senescent cells with targeting age related diseases and counteracting therapy resistance in late stage cancer. The company was founded by Peter de Keizer, Marco Demaria, Tobias Madl and is headquartered in Utrecht, the Netherlands. | Chairman | 2022-09-26 |
Former positions of Angelos Stergiou
| Companies | Position | End |
|---|---|---|
| Kentucky Wesleyan College | Director/Board Member | 2020-12-31 |
Genesis Research LLC
 Genesis Research LLC Miscellaneous Commercial ServicesCommercial Services Genesis Research LLC provides pharmaceuticals services. It offers medical, scientific writing, simulation, artificial intelligence, machine learning, and natural language processing. The company was founded by Steven R. Arikian and Frank A. Corvino in 2009 and is headquartered in Hoboken, NJ. | Chief Executive Officer | 2010-12-31 |
| ░░░░░░░░ ░░░░░░░░░░░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Training of Angelos Stergiou
| Kentucky Wesleyan College | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| ANAVEX LIFE SCIENCES CORP. | Health Technology |
| SELLAS LIFE SCIENCES GROUP, INC. | Health Technology |
| Private companies | 10 |
|---|---|
BioVest International, Inc.
 BioVest International, Inc. Medical SpecialtiesHealth Technology BioVest International, Inc. develops and commercializes personalized therapeutic cancer vaccine for the treatment of B-cell blood cancers. The firm continued development, commercialization, manufacture and sale of AutovaxID and other instruments and disposables; and the commercial sale and production of cell culture products and services. The company was founded in 1981 and is headquartered in Tampa, FL. | Health Technology |
Accentia Biopharmaceuticals, Inc.
 Accentia Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Accentia Biopharmaceuticals, Inc. engages in the commercialization of patent-protected disruptive healthcare technologies. It offers products under the BiovaxID., Revimmune, and SinuNase brands. The company was founded in 2002 and is headquartered in Tampa, FL. | Health Technology |
New York Academy of Sciences
New York Academy of Sciences Miscellaneous Commercial ServicesCommercial Services New York Academy of Sciences is an independent, not-for-profit organization, which engages in the advancement of scientific research, education, and policy. The company was founded in 1817 and is headquartered in New York, NY. | Commercial Services |
| Academy of Physicians In Clinical Research | |
Association of Clinical Research Professionals
Association of Clinical Research Professionals Miscellaneous Commercial ServicesCommercial Services The Association of Clinical Research Professionals is a non-profit organization that provides over 50 online and in-person training programs for individual sale and institutional licensing. The non-profit company is based in Alexandria, VA and was founded by Lynn E. Regina. The company's courses cover good clinical practice (GCP) and specialized topics, including the anatomy of a protocol, hypothesis development, study design, subject safety, and data integrity risk considerations. The company also offers clinical trial insights research, a solution that combines market research capabilities with unprecedented access. With over 13,000 members, the organization represents, supports, and advocates for clinical research professionals. | Commercial Services |
| The World Medical Association | |
SELLAS Life Sciences Group, Inc. /Old/
 SELLAS Life Sciences Group, Inc. /Old/ BiotechnologyHealth Technology SELLAS Life Sciences Group, Inc. /Old/ is based in New York, NY. SELLAS Life Sciences Group, Inc. is a clinical-stage biopharmaceutical company. | Health Technology |
Genesis Research LLC
Genesis Research LLC Miscellaneous Commercial ServicesCommercial Services Genesis Research LLC provides pharmaceuticals services. It offers medical, scientific writing, simulation, artificial intelligence, machine learning, and natural language processing. The company was founded by Steven R. Arikian and Frank A. Corvino in 2009 and is headquartered in Hoboken, NJ. | Commercial Services |
Cleara Biotech BV
Cleara Biotech BV Pharmaceuticals: MajorHealth Technology Cleara Biotech BV operates as a biopharmaceutical company. It specializes in identification and specific elimination of subtypes of senescent cells with targeting age related diseases and counteracting therapy resistance in late stage cancer. The company was founded by Peter de Keizer, Marco Demaria, Tobias Madl and is headquartered in Utrecht, the Netherlands. | Health Technology |
Sellas Life Sciences Group Ltd.
Sellas Life Sciences Group Ltd. Pharmaceuticals: MajorHealth Technology Sellas Life Sciences Group Ltd. manufactures pharmaceutical products. It focuses on innovative products to treat cancer and central nervous system diseases. The firm’s product candidate, licensed from Memorial Sloan-Kettering Cancer Center is a late-stage innovative WT1-targeting synthetic heteroclitic epitope immunotherapeutic in development for hematological malignancies and solid tumors characterized by an overexpression of the WT1 (Wilms Tumor Protein) antigen. The company was founded by Angelos M. Stergiou in 2012 and is headquartered in Zug, Switzerland. | Health Technology |
- Stock Market
- Insiders
- Angelos Stergiou
